5‑Amino‑1MQ
Experimental metabolism-boosting compound (NNMT blocker): reduced fat tissue in animal studies, not studied in humans.
The links above are labelled third-party affiliate links. MolekulaX does not sell and does not verify product quality.

DETAILED OVERVIEW
What is 5-Amino-1MQ?
5-Amino-1MQ is an experimental compound that is not a peptide but a small molecule, and it blocks an enzyme called NNMT in the hope of speeding up metabolism. It has not been approved as a medicine anywhere, and it is sold online as a research chemical.
So far it has been studied only in animals: in animal models of obesity it reduced fat tissue and improved insulin sensitivity. Its effects and safety in humans are unknown. Products sold online may differ from the label and may be contaminated. It must not be used in pregnancy or breastfeeding, because nothing is known about its effects then. It is not listed separately on the anti-doping list, but the general ban on unapproved substances means it can lead to a sanction in competitive sport.
Type
Blocker of the NNMT enzyme; small molecule, not a peptide
Status
Preclinical
Route
Oral
Storage
2–8°C
Metabolic support
Glucose and lipid metabolism shift favorably: insulin sensitivity improves, glycemic swings and HbA1c drop, while LDL and triglycerides normalize. Body composition refines, fat mass decreases, lean mass is preserved or grows. Appetite is regulated both centrally and peripherally (GLP-1 / GIP / glucagon pathways), so caloric intake settles into a sustainable range without constant willpower. Energy expenditure and thermogenesis rise modestly.
Cellular renewal
The peptide acts on several aging fundamentals: telomerase activation slows telomere shortening; oxidative stress drops (Nrf2 / glutathione system); gene-expression patterns epigenetically normalize. Mitochondrial energy production improves, tissue-specific stem-cell activity is supported. On skin: collagen I/III synthesis rises, wrinkle depth shrinks, hydration and elasticity improve. Long-term, biomarkers (CRP, glucose, lipids) show younger patterns and epigenetic age can slow.
Community accounts describe 5-Amino-1MQ as highly regarded for fat loss, with users describing a subtle, background fat-loss effect that builds over time. Reports often include better day-long energy. Through NNMT inhibition, the compound lowers circulating NAD+ levels by retaining more NAD+ inside cells where it is metabolically active. It pairs well with compounds that actively boost metabolism – Cardarine, injectable L-Carnitine, or Retatrutide. Best framed as a daily background fat-loss optimizer rather than a primary driver.
5-Amino-1MQ can be administered orally (encapsulated formulations are available) or subcutaneously. If oral use causes stomach upset, taking it with food or extra water helps. Pre-cardio dosing is often considered ideal for performance applications.
⚠ Not clinical evidence – based on user accounts.
Data console
Lab data
Research indications
Investigated uses and mechanisms
Weight regulation
Reduced appetite and increased energy expenditure via GLP-1 / GIP / glucagon agonism.
Type 2 diabetes
Improved insulin sensitivity and HbA1c reduction in clinical trials.
Cardiometabolic profile
Favorable shifts in lipid profile and blood pressure.
Quality indicators
How to recognize a pure peptide
Purity markers
4White / off-white powder
Typical appearance of sterile lyophilized peptide.
Comes with COA (Certificate of Analysis)
Independent lab analysis, ≥98% purity.
Intact, sealed vial
Rubber stopper + aluminum crimp intact, ensuring sterility.
Dissolves clear
Clear solution after reconstitution, no sediment.
Use caution
1Storage temperature
Extended room-temp exposure may reduce potency.
Do not use
2Discoloration / sediment
Yellow, cloudy or particulate solution, indicates degradation, do not use.
Damaged packaging
Cracked vial or loose cap, sterility compromised, discard.
Safety
Side effects, stop signs, contraindications
Side effects · 5
- Nausea, headache, especially during titration
- Appetite and bowel-motility shifts
- Local skin reaction at injection site
- Transient blood-sugar variability (esp. in diabetics)
- Mild heart-rate increase
Contraindications · 5
- Pregnancy and breastfeeding
- Active malignancy
- Known allergy to the peptide or its components
- Severe hepatic or renal impairment (medical consultation required)
- Age under 18
Related Peptides
Same therapeutic category
Telegram
Have a question about 5‑Amino‑1MQ?
Reach out to an advisor on Telegram. We can help you find the right peptide.
Personalized consultation
Want a detailed conversation tailored to your data?
Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.
Fill out the form~5–7 min · prep questionnaire · confidential · GDPR-compliant
The information here is strictly for educational and scientific purposes. It does not replace medical advice or clinical consultation, and it does not encourage illegal substance or pharmaceutical use. Data is sourced. When in doubt, consult your doctor.
